These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28552758)

  • 1. Fluorescence polarization-based competition binding assay for c-Jun N-terminal kinases 1 and 2.
    Ansideri F; Dammann M; Boeckler FM; Koch P
    Anal Biochem; 2017 Sep; 532():26-28. PubMed ID: 28552758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3.
    Christopher JA; Atkinson FL; Bax BD; Brown MJ; Champigny AC; Chuang TT; Jones EJ; Mosley JE; Musgrave JR
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2230-4. PubMed ID: 19303774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Cho YY; Bode AM; Vummenthala A; Park JG; Liu K; Pang YP; Dong Z
    FEBS Lett; 2009 Jul; 583(13):2208-12. PubMed ID: 19527717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence polarization-based assays for detecting compounds binding to inactive c-Jun N-terminal kinase 3 and p38α mitogen-activated protein kinase.
    Ansideri F; Lange A; El-Gokha A; Boeckler FM; Koch P
    Anal Biochem; 2016 Jun; 503():28-40. PubMed ID: 26954235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
    Barnat M; Enslen H; Propst F; Davis RJ; Soares S; Nothias F
    J Neurosci; 2010 Jun; 30(23):7804-16. PubMed ID: 20534829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
    Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration.
    Probst GD; Bowers S; Sealy JM; Truong AP; Hom RK; Galemmo RA; Konradi AW; Sham HL; Quincy DA; Pan H; Yao N; Lin M; Tóth G; Artis DR; Zmolek W; Wong K; Qin A; Lorentzen C; Nakamura DF; Quinn KP; Sauer JM; Powell K; Ruslim L; Wright S; Chereau D; Ren Z; Anderson JP; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2011 Jan; 21(1):315-9. PubMed ID: 21112785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.
    Prause M; Christensen DP; Billestrup N; Mandrup-Poulsen T
    PLoS One; 2014; 9(1):e87067. PubMed ID: 24475223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.
    Lu W; Liu Y; Gao Y; Geng Q; Gurbani D; Li L; Ficarro SB; Meyer CJ; Sinha D; You I; Tse J; He Z; Ji W; Che J; Kim AY; Yu T; Wen K; Anderson KC; Marto JA; Westover KD; Zhang T; Gray NS
    J Med Chem; 2023 Mar; 66(5):3356-3371. PubMed ID: 36826833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.
    Szczepankiewicz BG; Kosogof C; Nelson LT; Liu G; Liu B; Zhao H; Serby MD; Xin Z; Liu M; Gum RJ; Haasch DL; Wang S; Clampit JE; Johnson EF; Lubben TH; Stashko MA; Olejniczak ET; Sun C; Dorwin SA; Haskins K; Abad-Zapatero C; Fry EH; Hutchins CW; Sham HL; Rondinone CM; Trevillyan JM
    J Med Chem; 2006 Jun; 49(12):3563-80. PubMed ID: 16759099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All JNKs can kill, but nuclear localization is critical for neuronal death.
    Björkblom B; Vainio JC; Hongisto V; Herdegen T; Courtney MJ; Coffey ET
    J Biol Chem; 2008 Jul; 283(28):19704-13. PubMed ID: 18474608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazoles.
    Park H; Iqbal S; Hernandez P; Mora R; Zheng K; Feng Y; LoGrasso P
    Sci Rep; 2015 Jan; 5():8047. PubMed ID: 25623238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
    Abdelli S; Bonny C
    PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Alam M; Beevers RE; Ceska T; Davenport RJ; Dickson KM; Fortunato M; Gowers L; Haughan AF; James LA; Jones MW; Kinsella N; Lowe C; Meissner JW; Nicolas AL; Perry BG; Phillips DJ; Pitt WR; Platt A; Ratcliffe AJ; Sharpe A; Tait LJ
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3463-7. PubMed ID: 17459703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain JNK and metabolic disease.
    Nogueiras R; Sabio G
    Diabetologia; 2021 Feb; 64(2):265-274. PubMed ID: 33200240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Chen H; Lee MH; Li H; Ma W; Peng C; Song NR; Lee KW; Bode AM; Dong Z; Dong Z
    Cancer Prev Res (Phila); 2014 Jan; 7(1):139-49. PubMed ID: 24253317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.